Bioheuris
PrivateLast Round
VC Round
Jan 28, 2022
Company Overview
Bioheuris operates in Healthcare & Life Sciences and is based in Rosario. Its latest recorded funding round was a VC Round in January 2022.
Bioheuris is an agtech company that develops gene-edited traits to enhance weed management in crops using CRISPR-based technologies, protein-directed evolution, and precision breeding.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bioheuris Comparables
Compare Bioheuris with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neocrop Technologies | 80% | |
| Hudson River Biotechnology | 79% | |
| Phytoform Labs | 79% |
For institutional investors. Book with your work email.
Bioheuris Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jan 28, 2022 | ||||
| Accelerator | Jun 3, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Bioheuris Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Aceleradora Litoral | VC Round, Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 7, 2025
Web traffic grew 50% MoM (from 168 to 252 monthly visitors)
- Oct 30, 2024
Monthly visitors grew 663% MoM, from 46 to 351.
For institutional investors. Book with your work email.
Bioheuris Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Bioheuris's valuation, stock price, and market status.
Is Bioheuris a public or private company?
Bioheuris is a private company.
What is the current stock price of Bioheuris?
Bioheuris is a private company, so its shares have no public market price. Caplight tracks Bioheuris's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Bioheuris worth (valuation)?
Valuation information for Bioheuris is not publicly available.
Can I buy Bioheuris stock?
Bioheuris shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Bioheuris's last funding round?
Bioheuris's most recent funding round was VC Round on January 28, 2022.
Who are the main investors in Bioheuris?
Key investors in Bioheuris include Aceleradora Litoral.
Will Bioheuris IPO soon?
No public IPO plans have been announced for Bioheuris.
How can I track Bioheuris secondary market activity?
Caplight tracks bids, offers, and trades in Bioheuris's shares on secondary markets.